Cumberland Pharmaceuticals Inc.
CPIX
$4.35
-$1.01-18.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.08% | -3.19% | -348.15% | -481.30% | -110.83% |
| Total Depreciation and Amortization | 2.52% | 4.73% | 14.16% | 14.56% | 13.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -127.30% | -174.65% | 192.62% | 193.32% | 183.57% |
| Change in Net Operating Assets | -9.39% | -72.10% | -78.87% | -78.61% | -60.40% |
| Cash from Operations | 0.88% | -110.05% | -116.99% | -107.09% | -25.19% |
| Capital Expenditure | 66.37% | 76.36% | -42.73% | -28.28% | -18.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -559.64% | -29.21% | 149.36% | 285.43% | 281.54% |
| Cash from Investing | -10,692.38% | 154.63% | 134.27% | 126.16% | 103.42% |
| Total Debt Issued | -20.26% | 22.28% | 35.74% | 25.33% | -15.71% |
| Total Debt Repaid | -11.23% | -3.17% | -7.97% | 3.41% | 23.12% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 27.94% | 21.82% | 9.67% | -25.67% | -21.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 34.42% | 47.49% | 24.67% | 27.73% | 23.24% |
| Cash from Financing | -140.44% | 102.65% | 101.01% | 97.38% | 58.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -259.09% | 75.12% | -0.92% | -2,907.69% | 345.56% |